The prospects of modifying the antimicrobial properties of milk

Biotechnology Advances

Volumn 19, Issue 4, 2001, Pages 299-316

  Kolb, Andreas F ^a  

^a HANNAH RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Immunology; Milk; Neutralization; Pathogen; Protection

Indexed keywords

ANTIMICROBIAL ACTIVITY; BREAST MILK; CHEMICAL COMPOSITION; FOOD ANALYSIS; LACTATION; MAMMARY GLAND; MILK;

ANTIBODIES; BIOLOGICAL ORGANS; HEALTH CARE; PATHOLOGY;

ANTIMICROBIAL PROPERTIES;

BIOTECHNOLOGY;

ANTIMICROBIAL ACTIVITY;

EID: 0034914147     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0734-9750(01)00069-6     Document Type: Article

References (90)

1. Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes
2. Lactoferrin is responsible for the fungistatic effect of human milk
3. Immunoglobulin-secreting cells of maternal origin can be detected in B cell-deficient mice
4. The effect of human milk on the adherence of enterohemorrhagic E. coli to rabbit intestinal cells
5. Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process
6. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex
7. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin
8. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin
9. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity
10. In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferrin
11. Identification of the complement regulatory protein CD59 in human colostrum and milk
12. Peptide antibiotics and their role in innate immunity
13. Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk
14. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111
15. Expression of full-length bioactive antimicrobial human lactoferrin in potato plants
16. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline
17. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells
18. Increased immunoglobulin A levels in milk by over-expressing the murine polymeric immunoglobulin receptor gene in the mammary gland epithelial cells of transgenic mice
19. Prophylaxis of rotavirus gastroenteritis using immunoglobulin
20. Passive immunizations of suckling mice and infants with bovine colostrum containing antibodies to human rotavirus
21. Passive protection against respiratory syncytial virus disease in infants: The role of maternal antibody
22. Prevention strategies for respiratory syncytial virus: Passive and active immunization
23. Maternal immunization against viral disease
24. Molecular basis of transmissible gastroenteritis virus epidemiology
25. Role of breast-feeding in managing malnutrition and infectious disease
26. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli
27. Maternal antibodies block malaria
28. Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective
29. Cytokines in human milk: Properties and potential effects upon the mammary gland and the neonate
30. Integrin alpha(v)beta(3) mediates rotavirus cell entry
31. Breastfeeding provides passive and likely long-lasting active immunity
32. The mother-offspring dyad and the immune system
33. The mammary gland-infant intestine immunologic dyad
34. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro
35. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin
36. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
37. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
38. Antiviral and antibacterial lipids in human milk and infant formula feeds
39. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice
40. Human milk lactoferrin binds two DNA molecules with different affinities
41. Inhibitory factors in breastmilk, maternal and infant sera against in vitro growth of Plasmodium falciparum malaria parasite
42. Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis
43. Generation of transgenic dairy cattle using 'in vitro' embryo production
44. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates
45. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14
46. Trace amounts of ganglioside GM1 in human milk inhibit enterotoxins from Vibrio cholerae and Escherichia coli
47. Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin peptides
48. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus
49. Immunoglobulins of the mammary secretions
50. Maternal rescue of transforming growth factor-beta 1 null mice
51. Identification and analysis of a Ca(2+)-dependent lactoferrin receptor in rat liver. Lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent manner
52. Inhibition of listeriolysin O-induced hemolysis by bovine lactoferrin
53. A step ahead. Infant protection through maternal immunization
54. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV
55. Oligosaccharides and glycoconjugates in human milk: Their role in host defense
56. Human milk glycoconjugates that inhibit pathogens
57. Human milk glycosaminoglycans inhibit HIV glycoprotein gp 120 binding to its host cell CD4 receptor
58. Role of human-milk lactadherin in protection against symptomatic rotavirus infection
59. Structure and biological actions of lactoferrin
60. Antibacterial activity of peptides homologous to a loop region in human lactoferrin
61. Cytotoxicity by stored human breast-milk: Possible contribution of complement system
62. Complement-mediated bactericidal activity of human milk to a serum-susceptible strain of E. coli 0111
63. Effect of breast feeding on the development of anti-idiotype antibody response to F glycoprotein of respiratory syncytial virus in infant mice after post-partum maternal immunization
64. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice
65. Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule
66. Transgenic milk as a method for the production of recombinant antibodies
67. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae
68. Identification of two distinct antibacterial domains within the sequence of bovine alpha(s2)-casein
69. Killing of Giardia lamblia by human milk is mediated by unsaturated fatty acids
70. Production of human lactoferrin in transgenic tobacco plants
71. Effects of varying degrees of heat treatment on milk protein and its nutritional consequences
72. Transgenic mice secreting coronavirus neutralizing antibodies into the milk
73. Antibodies from colostrum in oral immunotherapy
74. Antibacterial activity of 15-residue lactoferricin derivatives
75. Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa
76. Structure of recombinant human lactoferrin expressed in Aspergillus awamori
77. Antiviral effects of milk proteins: Acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro
78. Lactoferrin. Antiviral activity of lactoferrin
79. Charge modification of plasma and milk proteins results in antiviral active compounds
80. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study
81. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein
82. DNA inoculation with a plasmid vector carrying the faeG adhesin gene of Escherichia coli K88ab induced immune responses in mice and pigs
83. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes
84. Apoptosis of Caco-2 intestinal cells invaded by Listeria monocytogenes: Protective effect of lactoferrin
85. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori
86. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models
87. Toward designer milk
88. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis
89. Two independent pathways of maternal cell transmission to offspring: Through placenta during pregnancy and by breast-feeding after birth
90. Casocidin-I: A casein-alpha s2 derived peptide exhibits antibacterial activity